ERNA vs MAR · P/E 0.0, rev $582.0K vs P/E 32, rev $26.19B
Eterna Therapeutics Inc (ERNA) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the ERNA and MAR stock pages for the full models.
Not investment advice.